Keywords: expanded, indication, gsk, bexxar, glaxosmithkline, says, food

Expanded indication for GSK's Bexxar

Article | 10 January 2005

Print This

GlaxoSmithKline says that the US Food and Drug Administration has approved a supplemental Biologics License Application for the expanded use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in